(Date:12/1/2009)..., , NEW YORK, Dec. 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ..., http://www.reportlinker.com/p0164431/Industrial...strial Enzymes market is an oligopoly with few str...in niche market activities. Keen competition and c...
(Date:12/1/2009)..., , PLYMOUTH, Mass., Dec. 1 /PRNewswire/ ...m ) announced today results from the company spons...machandra Medical Center in Chennai, India using t...n-reconstructable Critical Limb Ischemia (CLI). Sr...international-associated institution based in Chen...
(Date:12/1/2009)..., , Former Majority Leader Richard G...cience, Medicine, Biotech Communities for "Best a...JERSEY CITY, N.J., Dec. 1 /PRNewswire-USNewswire/ ...in biopharmaceuticals, research, medicine and tech...r to discuss the importance of medical innovation ...
(Date:12/1/2009)..., , SARASOTA, Fla., Dec. 1 /PRNewswire/...ducts, Osprey Biotechnics Inc. of Sarasota has app... distributor. ,, Lake is located near Birmingh...eficial bacteria which serve the agricultural, was...are bred to be hungry and to open drain fields, an...
Breaking Biology Technology:Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5...L, Inc. (Amex:,ADL), headquartered in Tustin, Cali...ilin, China, through its wholly owned subsidiary J... biopharma company that,together with JPI, engages...proprietary pharmaceutical, health care and diagno...I,s subsidiary, JJB, won a supply contract,for the...
... Pharmaceuticals,Inc. (Amex: ANX ), a biopharmace... commercializing proprietary product candidates fo... announced today that Evan M. Levine, the,company,... position as,Chief Executive Officer and President...eptember 2006., The company also announced that J...
...re-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NA...ceutical and,medical device company, is scheduled ...eutical, Biotechnology and Medical Device Conferen...NY., Dr. William Hunter, Angiotech,s President an...on Tuesday, February 5, at the Grand Hyatt New,Yor...
Other Biology Technology:AMDL Wins Chinese Military Supply Agreement for Its Domperidone Product for up to $6.6 Million 2ADVENTRX Announces Consolidation of Clinical and Management Positions 2ADVENTRX Announces Consolidation of Clinical and Management Positions 3(Date:12/1/2009)...ner of the 2009 Inserm Grand Prix., Every year s...aying tribute to outstanding,work performed in it...ts, Inserm intends to,demonstrate the diversity a...ical, medical and,health research, and the creati...t and,drive this research each day. The Inserm 20...
(Date:12/1/2009)...t-and-run attacks by sharks can be solved with a n...nique chomp they put on their victims, according t...ert. , In a method analogous to analyzing human ...by precisely comparing shark bites to the jaws and...ess, director of the International Shark Attack Fi...
(Date:12/1/2009)...onash University-led international research team h... of the next generation of solar cells. , Scient...olleagues from the universities of Wollongong and ...d solar cells with a three-fold increase in energy...ported tandem dye-sensitised solar cells. , Lea...
Breaking Biology News(10 mins):Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Innovation puts next-generation solar cells on the horizon 2Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 1Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 2Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 3Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 4Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 5Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 6Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once Daily Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 CII Prov 13143 7Abbott HIV Test Demonstrates Earlier Disease Detection 13141 1Abbott HIV Test Demonstrates Earlier Disease Detection 13141 2Abbott HIV Test Demonstrates Earlier Disease Detection 13141 3Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 1Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 2Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 3Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 4Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study 52380 5...hnstone and M.W. Turner (1997). • This book d...e production of high-quality antibodies, the use o...of antibodies and antigens, the latest ELISA techn...noassays for detecting cell-surface molecules (cel...
1-D PAGE Cleavable ICAT Reagent Applications Development Kit for Targeted Protein ID and Quantitation (monoplex Version) from Applied Biosystems
Thermal Printer Paper for Monolight Luminometer 1 each from BD Biosciences Pharmingen
Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG
Biology Products: